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Abstract 
 
Schiff bases of 2,4,5-triphenyl-1H-imidazole ligand and Cu (II) complex has been synthesized and characterized 
by 
1
H and 
13
C NMR, elemental analyses, molar conductance, thermal analysis (TGA), magnetic moment 
measurement, IR and UV-Vis. On the basis spectral studied and analytical data, it is evident that the Schiff base 
acts as monodentat ligand coordinating via nitrogen atom. The result showed that Cu (II) complex has octahedral 
geometry. The studied complex was tested for anticancer activity. The anticancer activity of Cu (II) complex is 
evaluated against liver Carninoma (HEPG2) cell lines. These compounds exhibit a moderate and weak activity 
against HCT 116 cell line with IC50 19.8 M. 
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1. INTRODUCTION 
 
Imidazole derivatives have been 
shown to exhibit interesting biological 
activities, including anti-allergy, anti-tumor, 
anti-inflammatory, anti-bacterial, and analgesic 
(Shelke et al., 2009; Wang et al., 2001; 
Mohammadi et al., 2012; Joshi et al., 2010; 
Ucucu et al., 2001). Hence, imidazole plays an 
important role in biochemistry, medical 
science, non linear optical materials and so on. 
Researches on complex compounds as 
anticancer have been developed until now 
many studies of new anticancer drugs made of 
metal that have been reported. Metal attached 
directly to an organic compound is called 
organomettalic compounds. Organomettalic 
complex can be classified based on cytotoxic 
activity against cancer cells by looking at the 
chemical-physical processes that enable the 
interactions toward biological targets (Sadler, 
1991). 
In some studies, the imidazole 
derivatives are widely used as ligands in the 
formation of complex compounds. Imidazole 
derivatives provide good antimicrobial 
activity. One of the examples is the formation 
of complex with the 2-(4-thiazolyl)-1H-
benzimidazole and benzimidazole ligand. 2-(4-
thiazolyl)-1H-benzimidazole compound has 
antimicrobial and antifungal activity higher 
than benzimidazole (Rahmapreet et al., 2011). 
It happened because 2-(4-thiazolyl)-1H-
benzimidazole has more aromatic substituents. 
Imidazole derivatives with the substitution of 
fluorine, propylene, and aromatic 
tetrahydroquinoline can improve stability, 
bioactivity and biological activity. 2,4,5-
triphenyl-1H-imidazole has a structure that 
allows it to be a bridging ligand so that the 
possibility to form complex polymers are also 
quite high (Walia, 2011).  The polymer 
complexs have very good stability. 2,4,5-
triphenyl-1H-imidazoles can be used as a 
corrosion inhibitor as reported 
(Wahyuningrum, 2008). However, only few 
studies discuss its biological activity and 
toxicity. 
Therefore, the present work aims to 
synthesize Schiff base ligand 2,4,5-Triphenyl-
1H-Imidazole and its complex with Cu(II) ion. 
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The complex has been characterized by several 
tools of analyses such as 
1
H and 
13
H NMR, 
elemental analyses, molar conductance, 
thermal analysis (TGA), magnetic moment 
measurement, IR and UV-Vis spectra. Also, 
anticancer activity of the synthesized 
compound has been studied.  
 
2. MATERIAL AND METHODE 
 
Materials 
All compounds used in the present 
study were of pure grade available from 
Merck. The solvents used for the spectral 
studies were spectroscopic grade from Aldrich. 
 
Instrumentations 
The elemental microanalyses of the 
solid compound was performed at the micro 
analytical center, 
1
H-NMR and 
13
C-NMR Jeol 
500, University Kebangsaan Malaysia using 
Perkin Elmer 2400 CHN Elemental analyzer, 
Metal content was estimated using Atomic 
Absorption Spectroscpy (AAS) ZEEnit 700, 
Molar conductivities in DMF (10
-3
 M) at room 
temperature (27 C) were measured using 
Mettler Toledo, The infrared spectra were 
recorded using 8400S Shimadzu FTIR 
spectrophotometer within the range 4000-400 
cm
-1
 as KBr discs.  The electronic absorption 
were recorded using a genesys 10S UV-Vis 
spectrophotometer.  The room temperature 
magnetic susceptibility of the solid samples 
was measured using magnetic susceptibility 
balance (MSB) Sherwood Scientific LTD 1 
employing the Gouys method.  The 
thermogravimetric analysis (TGA) of the solid 
samples was performed within the temperature 
range 25-500 C using the STAR SW 10.00 
thermogravimetric analyzer with heating rate 
(10 C/min) under nitrogen atmosfir. 
 
Synthesis of 2,4,5-triphenyl-1H-imidazoles 
Ligand 
The Schiff base ligand (Fig. 1) was 
prepared by the reflux of benzyl (0.82 g, 3.8 
mmol), (1.52 g, 19.7 mmol)  ammonium 
acetate and 0.3 mL benzaldehyde in 30 mL 
acetate acid. A mixture of them was refluxed 
for 2.5 h. The reaction mixture was then 
poured onto ice water. The product which 
separated immediately was filtered off, washed 
several times with cold water and finally dried 
in a vacuum desiccators over anhydrous 
calcium chloride. 
 
 
 
Figure 1.  The structure of Schiff base 2,4,5-
triphenyl-1H-imidazoles ligand 
 
 
Synthesis of Complex Cu(II) with 2,4,5-
triphenyl-1H-imidazoles Ligand 
To a solution of ligand (0.29 g, 1 
mmol) in 20 ml methanol, a methanol (20 ml) 
of the hydrated Cu (II) nitrate (0.12 gram, 0,5 
mmol Cu(NO3)2
.
3H2O) was added slowly with 
constant stirring. The reaction mixture was 
heated to reflux for 24 h. The resulting mixture 
was filtered off and then left to evaporate in a 
beaker in air at ambient temperature. Green 
crystal were formed within several days. 
 
3. RESULTS AND DISCUSSION 
 
Elemental Analysis and Atomic Absorption 
Spectrophotometer Analysis 
Levels of metal ions Cu (II) complex 
synthesis product is determined by atomic 
absorption spectroscopy instruments. Snippets 
can be measured by the instrument SSA 
tangible solution. The complex is not soluble 
in distilled water. The compound was 
destructed in HNO3 solution, then added with 
aquademin. 
  
Table 1. Result of elemental analysis complex Cu(II) with 2,4,5-triphenyl-1H-imidazoles 
 
Complex % C % H % N % Cu 
 Found Calculated Found Calculated Found Calculated Found Calculated 
[CuL2(H2O)2](NO3)2 61.27 61.84 4.83 4.42 10.67 10.31 7.59 7.73 
  L = 2,4,5-triphenyl-1H-imidazole 
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The result of the elemental analysis on 
the precipitated complex are reported in Table 
2. Calculated and found element percent are in 
good agreement. It can be noted that the 
complex do not have the external water 
molecules even if the experimental conditions 
previously reported were strictly followed. It 
can be due to the drying process that removes 
all the unstructured water molecules. 
 
Magnetic Moment Measurement 
  The magnetic moment data of the solid 
complexes at room temperature showed that all 
complex are paramagnetic. The magnetic 
moment value of Cu (II) complex (1.96 BM) is 
higher than the theoretical spin only value of 
Cu (II) complex refers to spin orbital coupling. 
These values indicate octahedral structure for 
complex Cu (II). 
 
FT-IR  
The most important IR bands of 2,4,5-
triphenyl-1H-imidazoles ligand with their 
assignments are presented in fig 2. The ligand 
spectrum showed 3080, 1602, 1949 and 765 
cm
-1
 attributed, respectively to (CH, C=C, 
overtone aromatic, out of plane aromatic). 
Complex compounds [Cu(II)-2,4,5-triphenyl-
1H-imidazole (H2O)2](NO3)2 measured at wave 
number 3000-500 cm
-1
. This spectrum is used 
to determine the presence of functional groups 
in a complex compound that can assist in 
predicting the structure of complex 
compounds. In FTIR spectra, peaks widened at 
wave number 1600-1700 cm
-1 
 which indicates 
the presence of C-N bonded to the metal Cu 
with coordination ligand 2,4,5-triphenyl-1H-
imidazole. Peak in the area of 3039.60 cm
-1
 is a 
C-H bond stretching aromatic peak. In addition 
1600-1700 cm
-1
 is a vibration of C-N ligand 
2,4,5-triphenyl-1H-imidazole with 
coordination Cu logam. Cu-N bond is shown in 
wave numbers 422.38 cm
-1
. In the FTIR 
spectrum, NO3 bond of synthesized complex 
[Cu(II)-2,4,5-triphenyl-1H imidazole](NO3)2 
appears at wave number 1400 cm
-1
. While the 
Cu-O bond is observed at 534.25 cm
-1
 region. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2.  IR Spectra of the 2,4,5-triphenyl-1H-
imidazoles ligand and complex Cu(II) 
with 2,4,5-triphenyl-1H-imidazoles 
ligand 
 
 
NMR (
1
H and 
13
C) Spectra 
Its 
1
H and 
13
C NMR spectrum of 2,4,5-
triphenyl-1H-imidazoles ligand was recorded 
in d
6
-DMSO reported in table 1 and showed in 
figure 3 for 
1
H NMR figure 4 for 
13
C NMR.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 
1
H NMR of the 2,4,5-triphenyl-1H-imidazoles ligand 
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Figure 4. 
13
C NMR of the 2,4,5-triphenyl-1H-imidazoles ligand 
 
 
Table 2.   
1
H NMR and  
13
C NMR data of the 2,4,5-
triphenyl-1H-imidazoles ligand 
 
1
H NMR δ (ppm) 
13
C NMR δ (ppm) 
12.70 (s, 1H, NH) 
8.09 – 8.08 (d, 2H) 
7.56 – 7.55 (d) 
7.52 – 7.43 (m)  
7.31 – 7.36 (t) 
7.32-7.29 (t) 
7.24-7.21 (t) 
145.5; 137.1; 135.2; 
131.1; 130.3; 128.7; 
128.6; 128.5; 128.3; 
128.2; 127.8; 127.1; 
126.5; 125.2 
 
 
Molar Conductance 
 
Table 3. Molar conductance of Cu (II) complex 
 
Compound 
Λm 
(S.cm2.mol-1) 
Electrolyte 
Methanol 4.75 - 
KCl in methanol 98.57 1 : 1 
MgCl2 in methanol 157.45 2 : 1 
FeCl3 in methanol 258.85 3 : 1 
Complex Cu(II) in 
methanol 
161.05  2 : 1` 
 
 
Thermogravimetry Analysis 
Thermogravimetric analysis was used to 
estimate species that decompose or left. It can 
be determined by comparing the weight of the 
sample at a temperature of decomposition to 
the initial weight. The results of analysis by 
Thermal Gravimetric Analyser (TGA) of 
complex compounds Cu (II) is shown in Figure 
5. The analysis was performed with a heating 
rate of 10 ºC/h at 20-600 ºC and the initial 
sample weight of 23.7 mg. 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Thermogravimetry analysis of complex 
Cu (II) with 2,4,5-triphenyl-1H-
imidazole 
 
 
Based on the results of this analysis, it 
can be seen that the decomposition does not 
happen at temperature 120-150 ºC which 
indicates that the complex does not contain 
crystal water. Decomposition peak appeared at 
between 291.55-417.47 ºC. At this temperature 
decomposition was as much as 93.75%. At this 
temperature it was  predicted that mass loss 
was metal, the two ligand 2,4,5-triphenyl-1H-
imidazole, two water ligands, and  HNO3 
ligand. The predictions of complex compounds 
of formula [Cu(II)-2,4,5-triphenyl-1H-
imidazole (H2O)2](NO3)2. 
 
Toxicity Test 
 Toxicity tests were performed using 
the BSLT (Brine Shrimp Lethality Test) 
Temperature 
o
C 
W
ei
g
h
t 
(%
) 
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method. Experimental animals used in this 
method is the larval of Artemiasalina shrimp. 
The LC50 values will be obtained from this test. 
This value is used to determine the toxicity of 
a compound. Toxicity tests were performed 
using the BSLT (Brine Shrimp Lethality Test) 
method (Meyer, 1982). In this test, variations 
in the concentration used is 25 ppm, 50 ppm, 
100 ppm, 250 ppm, 500 ppm and 1000 ppm. 
The measurement was performed with three 
repetitions (triplo) for each concentration .Data 
on the number of deaths in each of various 
concentrations shown in Table 4. Then log 
concentration against % mortality graph is 
shown in Figure 4 . 
 
Table 4 . LC50 value with BSLT method 
 
Concentration 
ppm 
Log Dead Life % 
Mortality 
25 1.40 0 31 0.00 
50 1.70 2 30 2.02 
100 2.00 6 25 10.67 
250 2.40 8 24 27.59 
500 2.70 12 18 60.87 
1000 3.00 31 0 100.00 
 
 
Through calculations using polynomial 
regression equation in Figure 5, it is known 
that the LC50values is 389.04 mg/L (complete 
calculation in appendix). LC50 value of the 
complex Cu (II)-2,4,5-triphenyl-1H-imidazole 
proven research (Walia et al., 2011) that the 
more aromatic compounds in the complex can 
enhance the stability and biological activity. 
LC50 value obtained is greater than the value of 
the pure compound toxicity limit which is 200 
ppm. 
 
 
 
Figure 5. BSLT (Brine Shrimp Lethality Test) 
Anticancer Activity 
Cu (II) complex with 2,4,5-triphenyl-
1H-imidazole ligand has been sought for 
anticancer treatment. The values of IC50, 
compared with the standard drug doxorubicin 
(Drox) the liver Carninoma (HEPG2) are 
collected in Table 4. Untreated cells were used 
as a control. The ligand and Cu(II) complex 
showed an inhibition of cell viability and gave 
the IC50 value 8.7 M and 19.8 M against 
HEPG2, respectively, compared with IC50 
value of 4.73 M for the standard cytotoxin 
drug doxorubicin. 
 
4. CONCLUSION 
 
A schiff base of 2,4,5-triphenyl-1H-
imidazole ligand and Cu(II) complexes were 
synthesized and characterized by 
1
H and 
13
C 
NMR, elemental analyses, molar conductance, 
thermal analysis (TGA), magnetic moment 
measurement, IR and UV-Vis. On the basis 
spectral studie and analytical data, it is evident 
that the Schiff base acts as monodentat ligand 
coordinating via nitrogen atom.. The Cu(II) 
complex have octahedral geometry. The 
kinetic and thermodynamic parameters of the 
thermal decomposition stages have been 
evaluated using Coats. Redfern method.  In 
vitro anticancer activity of these complexes 
showed IC50 19.8 M. 
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